MC really look forward to your take. I picked up more at 52 dollars just now. I am simply amazed at some of these analysts. We all know how hard it is to place a value on a company like this and for some person to look at these results and say, “it looks rather ambiguous to me” would make sense, but to say, “the company is now worth 73 dollars a share as opposed to 91.50” or some such nonsense is crazy.
How do you get one of those jobs? I have no idea how much NKTR might be worth if and when some of their drugs are approved, but these people are so sloppy it is sad.
Just my thoughts
Mike
1 Like